Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989731764> ?p ?o ?g. }
- W2989731764 abstract "Abstract Diabetes worsens atherosclerosis progression and leads to a defect in repair of arteries after cholesterol reduction, a process termed regression. Empagliflozin reduces blood glucose levels via inhibition of the sodium glucose cotransporter 2 (SGLT-2) in the kidney and has been shown to lead to a marked reduction in cardiovascular events in humans. To determine whether glucose lowering by empagliflozin accelerates atherosclerosis regression in a mouse model, male C57BL/6J mice were treated intraperitoneally with LDLR- and SRB1- antisense oligonucleotides and fed a high cholesterol diet for 16 weeks to induce severe hypercholesterolemia and atherosclerosis progression . At week 14 all mice were rendered diabetic by streptozotocin (STZ) injections. At week 16 a baseline group was sacrificed and displayed substantial atherosclerosis of the aortic root. In the remaining mice, plasma cholesterol was lowered by switching to chow diet and treatment with LDLR sense oligonucleotides to induce atherosclerosis regression . These mice then received either empagliflozin or vehicle for three weeks. Atherosclerotic plaques in the empagliflozin treated mice were significantly smaller, showed decreased lipid and CD68 + macrophage content, as well as greater collagen content. Proliferation of plaque resident macrophages and leukocyte adhesion to the vascular wall were significantly decreased in empagliflozin-treated mice. In summary, plasma glucose lowering by empagliflozin improves plaque regression in diabetic mice." @default.
- W2989731764 created "2019-12-05" @default.
- W2989731764 creator A5015202871 @default.
- W2989731764 creator A5021427999 @default.
- W2989731764 creator A5031102353 @default.
- W2989731764 creator A5037048973 @default.
- W2989731764 creator A5039523683 @default.
- W2989731764 creator A5042115290 @default.
- W2989731764 creator A5046594613 @default.
- W2989731764 creator A5050546282 @default.
- W2989731764 creator A5056460526 @default.
- W2989731764 creator A5058111091 @default.
- W2989731764 creator A5064135269 @default.
- W2989731764 creator A5066507748 @default.
- W2989731764 creator A5071826547 @default.
- W2989731764 creator A5073821468 @default.
- W2989731764 creator A5091773852 @default.
- W2989731764 date "2019-11-29" @default.
- W2989731764 modified "2023-10-17" @default.
- W2989731764 title "Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice" @default.
- W2989731764 cites W1493021887 @default.
- W2989731764 cites W1571614320 @default.
- W2989731764 cites W1590077295 @default.
- W2989731764 cites W1947868419 @default.
- W2989731764 cites W1970845955 @default.
- W2989731764 cites W1972914668 @default.
- W2989731764 cites W1973433801 @default.
- W2989731764 cites W1982731795 @default.
- W2989731764 cites W1991611671 @default.
- W2989731764 cites W1995299599 @default.
- W2989731764 cites W1996209259 @default.
- W2989731764 cites W2028858008 @default.
- W2989731764 cites W2031047943 @default.
- W2989731764 cites W2046099126 @default.
- W2989731764 cites W2052554962 @default.
- W2989731764 cites W2054506834 @default.
- W2989731764 cites W2063643017 @default.
- W2989731764 cites W2064255959 @default.
- W2989731764 cites W2065840659 @default.
- W2989731764 cites W2074375778 @default.
- W2989731764 cites W2075812158 @default.
- W2989731764 cites W2079724669 @default.
- W2989731764 cites W2081850992 @default.
- W2989731764 cites W2090921446 @default.
- W2989731764 cites W2100945845 @default.
- W2989731764 cites W2103105662 @default.
- W2989731764 cites W2116643669 @default.
- W2989731764 cites W2120780093 @default.
- W2989731764 cites W2123002906 @default.
- W2989731764 cites W2127933204 @default.
- W2989731764 cites W2128924195 @default.
- W2989731764 cites W2130086266 @default.
- W2989731764 cites W2131010118 @default.
- W2989731764 cites W2146264128 @default.
- W2989731764 cites W2153406260 @default.
- W2989731764 cites W2154500970 @default.
- W2989731764 cites W2158380859 @default.
- W2989731764 cites W2160183149 @default.
- W2989731764 cites W2161311866 @default.
- W2989731764 cites W2166118660 @default.
- W2989731764 cites W2170646719 @default.
- W2989731764 cites W2276012049 @default.
- W2989731764 cites W2283021481 @default.
- W2989731764 cites W2325194139 @default.
- W2989731764 cites W2341643234 @default.
- W2989731764 cites W2555543235 @default.
- W2989731764 cites W2587032970 @default.
- W2989731764 cites W2617488317 @default.
- W2989731764 cites W2653398740 @default.
- W2989731764 cites W2767654581 @default.
- W2989731764 cites W2783888432 @default.
- W2989731764 cites W2792768188 @default.
- W2989731764 cites W2916672270 @default.
- W2989731764 cites W2920609441 @default.
- W2989731764 cites W2936456541 @default.
- W2989731764 doi "https://doi.org/10.1038/s41598-019-54224-9" @default.
- W2989731764 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6884628" @default.
- W2989731764 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31784656" @default.
- W2989731764 hasPublicationYear "2019" @default.
- W2989731764 type Work @default.
- W2989731764 sameAs 2989731764 @default.
- W2989731764 citedByCount "40" @default.
- W2989731764 countsByYear W29897317642020 @default.
- W2989731764 countsByYear W29897317642021 @default.
- W2989731764 countsByYear W29897317642022 @default.
- W2989731764 countsByYear W29897317642023 @default.
- W2989731764 crossrefType "journal-article" @default.
- W2989731764 hasAuthorship W2989731764A5015202871 @default.
- W2989731764 hasAuthorship W2989731764A5021427999 @default.
- W2989731764 hasAuthorship W2989731764A5031102353 @default.
- W2989731764 hasAuthorship W2989731764A5037048973 @default.
- W2989731764 hasAuthorship W2989731764A5039523683 @default.
- W2989731764 hasAuthorship W2989731764A5042115290 @default.
- W2989731764 hasAuthorship W2989731764A5046594613 @default.
- W2989731764 hasAuthorship W2989731764A5050546282 @default.
- W2989731764 hasAuthorship W2989731764A5056460526 @default.
- W2989731764 hasAuthorship W2989731764A5058111091 @default.
- W2989731764 hasAuthorship W2989731764A5064135269 @default.
- W2989731764 hasAuthorship W2989731764A5066507748 @default.
- W2989731764 hasAuthorship W2989731764A5071826547 @default.